Information Library
Flexible outsourcing - Specialty Care
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
INNOVEX AND HEALTHCARE AT HOME ANNOUNCE JOINT VENTURE
September 29, 2009 - Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe. -
Outsourced commercial strategy for multi-market launch
August 13, 2009
This study looks at how a UK-based biotech company managed a 12-country launch by outsourcing its requirement for a top performing specialty sales force. Not only did they prove it could be done, but the launch was also achieved in record time and has continued to beat its KPIs. -
Blockbuster reaches 7 new markets in record time
August 13, 2009
This study looks at a fully paid up member of ‘Big Pharma’ and its preparation for the international launch of one of its blockbuster drugs. It examines how outsourcing enabled them to get to market in time and then quickly out-perform the competition. -
Outsourcing for Pan-European launch success
August 13, 2009
This study is about research company PharmaMar and the ambitious pan-European launch of their brand Yondelis®. And how, without any sales infrastructure, they were meeting and beating targets faster than anyone thought possible. -
International and Specialty Podcast
August 13, 2009
Our news anchor Sian Jones talks to the principle advocates of outsourcing specialty care and multi country sales teams and meets one customer who’s already convinced. -
Poised for success
June 16, 2009
Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility -
Multi-Country Market Development
March 20, 2009
When PharmaMar achieved EU authorization for the commercialization of Yondelis® in the treatment of advanced soft tissue sarcoma, the company faced a massive logistical challenge.
Page 1 of 1 (7 items)